Company Information

Company NameSenzime AB
Company Idea

Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients' neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 10 billion. The company's shares are listed on AktieTorget (ATORG: SEZI)

CEO  Lena Söderström
Chairman of the Board  Philip Siberg
Board  Sorin J. Brull
Terry Cross
Adam Dahlberg
Ulf Lindskog
Philip Siberg
Articles Of Association  Bolagsordning Senzime AB, 2016-04-27.PDF
Registration Number  556565-5734
Delivery Address  Vallvägen 4A
Zip Code  75651
Home Page  
e-Mail Address  
Telephone  018-51 56 40
Company Presentation (video)  Lena Söderström presenterar Senzime på Redeye 170321

Instrument Information

Stock Name  Senzime
Ticker Name  SEZI
ISIN Number  SE0002478776
OrderBookID  56147
Number of shares  36,172,643
Par value  0.125 SEK
First Traded  6/18/2008
Instrument Type  Share

Major Share Holders (according to Euroclear) - per 12/31/2016 **

NameCapital %Votes %
Pershing Llc.24.6124.61 
Aktieinvest Fk AB10.0810.08 
Adam Dahlberg7.307.30 
Ulf Lindskog5.535.53 
Ebba Fischer5.205.20 

** uppdateras kvartalsvis, ca 5 veckor efter kvartalets slut

  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se